Award

Transfusion Technology Products - LOVO instrument - med device CE marked

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST

This public procurement record has 1 release in its history.

Award

07 Mar 2025 at 11:51

UK5 - Transparency Notice
Summary of the contracting process

The Newcastle Upon Tyne Hospitals NHS Foundation Trust has completed a direct award procurement process for the provision of advanced therapy services involving two LOVO systems, titled "Transfusion Technology Products - LOVO instrument - med device CE marked." This process falls under the medical equipment industry category and is located in Newcastle upon Tyne, UK. The procurement, justified by the absence of competition and technical reasons, commenced on 21 March 2025 and will end on 20 March 2026. The total contract value is gross £225,600.00. The procurement method was a direct award as per Section 41, Schedule 5, due to the specific needs and stringent regulatory requirements associated with Cell and Gene Therapy (CGT) equipment.

This tender represents significant business growth opportunities, especially for companies specialising in advanced medical technologies and compliant with stringent regulatory standards. Businesses with expertise in manufacturing specialised medical devices, particularly in the field of CGT, which requires sophisticated biological, genetic, and engineering knowledge, would be well-suited to compete. Given the limited market competition and the high demand for automated, closed-system collection and processing equipment, there is potential for substantial business development in this niche yet emerging market as the adoption of CGT therapies continues to grow.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Transfusion Technology Products - LOVO instrument - med device CE marked

Notice Description

Advanced Therapies service for 2x LOVO systems. Direct Award Section 41, Schedule 5 - The justification is an absence of competition and technical reasons. CRCR240163

Procurement Information

* The LOVO MED is the only commercially available device with the correct level of CE Marking and the capability to handle all the techniques and processes our department requires. Alternatives on the market, would require the purchase of two different devices to cover the array of processes. * The LOVO system is tailored for larger volume applications, while the Cue system is optimized for small-volume processes. While there are only one or two alternative manufacturers in the field (or world) Fresenius Kabi's LOVO and Cue machines are specialised in the volumes they treat. * The choice of LOVO and Cue by CGT specialists has been based on Fresenius Kabi's systems due to the demand on specific criteria, such as volume capacity, automation level, and integration capabilities. * Fresenius Kabi's Cell and Gene therapy is unique in that it requires advanced biological, genetic, and engineering expertise. It is not a standard piece of equipment that sees many vendors. It involves complex processes such as gene editing, stem cell manipulation, and immune cell reprogramming, which demand specialized equipment and regulatory compliance. * Strict regulations from agencies like the FDA (U.S.), EMA (Europe), and MHRA (UK) govern CGT manufacturing, requiring companies to meet rigorous compliance standards. The regulatory involvement does put off many other manufacturers wishing to develop in this field due to such high focused compliance standards. * The market for CGT is still emerging, with fewer patients receiving these therapies compared to traditional drug treatments. As CGT adoption grows, demand for automated, closed-system collection and processing equipment will maybe increase. This could lead to more competition and innovation, but for now the choice is extremely limited and we are currently the devices of choice in this field.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04ea6f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/008323-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33100000 - Medical equipments

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£188,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
7 Mar 202511 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
7 Mar 202511 months ago
Contract Period
21 Mar 2025 - 20 Mar 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST
Contact Name
Not specified
Contact Email
helen.potts18@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
NEWCASTLE UPON TYNE
Postcode
NE7 7DN
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
Not specified
Local Authority
Newcastle upon Tyne
Electoral Ward
Dene & South Gosforth
Westminster Constituency
Newcastle upon Tyne North

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-04ea6f-2025-03-07T11:51:11Z",
    "date": "2025-03-07T11:51:11Z",
    "ocid": "ocds-h6vhtk-04ea6f",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PDCY-5582-YRHQ",
            "name": "The Newcastle Upon Tyne Hospitals NHS Foundation Trust",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PDCY-5582-YRHQ"
            },
            "address": {
                "streetAddress": "Regent Point",
                "locality": "NEWCASTLE UPON TYNE",
                "postalCode": "NE7 7DN",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKC22"
            },
            "contactPoint": {
                "email": "helen.potts18@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.newcastle-hospitals.nhs.uk",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PDCY-5582-YRHQ",
        "name": "The Newcastle Upon Tyne Hospitals NHS Foundation Trust"
    },
    "tender": {
        "id": "C340408",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Transfusion Technology Products - LOVO instrument - med device CE marked",
        "description": "Advanced Therapies service for 2x LOVO systems. Direct Award Section 41, Schedule 5 - The justification is an absence of competition and technical reasons. CRCR240163",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "* The LOVO MED is the only commercially available device with the correct level of CE Marking and the capability to handle all the techniques and processes our department requires. Alternatives on the market, would require the purchase of two different devices to cover the array of processes. * The LOVO system is tailored for larger volume applications, while the Cue system is optimized for small-volume processes. While there are only one or two alternative manufacturers in the field (or world) Fresenius Kabi's LOVO and Cue machines are specialised in the volumes they treat. * The choice of LOVO and Cue by CGT specialists has been based on Fresenius Kabi's systems due to the demand on specific criteria, such as volume capacity, automation level, and integration capabilities. * Fresenius Kabi's Cell and Gene therapy is unique in that it requires advanced biological, genetic, and engineering expertise. It is not a standard piece of equipment that sees many vendors. It involves complex processes such as gene editing, stem cell manipulation, and immune cell reprogramming, which demand specialized equipment and regulatory compliance. * Strict regulations from agencies like the FDA (U.S.), EMA (Europe), and MHRA (UK) govern CGT manufacturing, requiring companies to meet rigorous compliance standards. The regulatory involvement does put off many other manufacturers wishing to develop in this field due to such high focused compliance standards. * The market for CGT is still emerging, with fewer patients receiving these therapies compared to traditional drug treatments. As CGT adoption grows, demand for automated, closed-system collection and processing equipment will maybe increase. This could lead to more competition and innovation, but for now the choice is extremely limited and we are currently the devices of choice in this field.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersTechnicalReasons"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Transfusion Technology Products - LOVO instrument - med device CE marked",
            "status": "pending",
            "value": {
                "amountGross": 225600,
                "amount": 188000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33100000",
                            "description": "Medical equipments"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2025-03-21T00:00:00Z",
                "endDate": "2026-03-20T23:59:59Z"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "008323-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/008323-2025",
                    "datePublished": "2025-03-07T11:51:11Z",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-03-20T23:59:59Z",
                    "status": "scheduled"
                }
            ]
        }
    ],
    "language": "en"
}